Indications and uses
temporarily relieves cough due to minor throat and bronchial irritations as may occur with the common cold or inhaled irritants helps loosen phlegm (mucus) and thin bronchial secretions to make cough more productive
temporarily relieves cough due to minor throat and bronchial irritations as may occur with the common cold or inhaled irritants helps loosen phlegm (mucus) and thin bronchial secretions to make cough more productive
take every 4 hours do not exceed 6 doses in 24 hours a special measuring device should be used to give an accurate dose of this product to children under 6 years of age giving a higher dose than recommended by a doctor can result in serious side effects for a child adults and children 12 years and over 10 mL (2 teaspoonfuls) children 6 to under 12 years of age 5 mL (1 teaspoonful) children under 6 years of age Con...
Sodium Content: 5 mg/5 mL Tamper evident: Do not use if seal under cap is broken or missing Keep container closed and store away from heat Store at 20°- 25°C (68°-77°F)
Drug Facts
| Active ingredients in each 5 mL (teaspoonful) | Purposes |
|---|---|
| Codeine Phosphate, USP 10 mg | Cough Suppressant |
| Guaifenesin, USP 100 mg | Expectorant |
Ask a doctor or pharmacist before use if you aretaking sedatives, tranquilizers and drugs used for depression, especially monoamine oxidase inhibitors (MAOIs). These combinations may cause greater sedation (drowsiness) than is caused by the product used alone.
If pregnant or breast-feeding,ask a health professional before use.
Keep out of reach of children.In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately.
| adults and children 12 years and over | 10 mL (2 teaspoonfuls) |
| children 6 to under 12 years of age | 5 mL (1 teaspoonful) |
| children under 6 years of age | Consult a doctor |
Citric acid, edetate disodium, FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, flavor, glycerin, menthol, propylene glycol, purified water, sodium benzoate, sodium citrate, sodium saccharin and sorbitol.
Call 1-800-845-8210 or visit paipharma.com
Serious side effects associated with use of this product may be reported to this number.
NDC 0121-0775-16
Guaifenesin and Codeine
Phosphate Oral Solution USP
CV
100 mg/10 mg per 5 mL
Expectorant / Cough Suppressant
Alcohol Free / Sugar Free
Each teaspoonful (5 mL) contains:
Guaifenesin, USP 100 mg
Codeine Phosphate, USP 10 mg
Dispense in a tight, light-resistant
container with a child-resistant closure.
DO NOT ACCEPT IF SEAL
AROUND CAP IS BROKEN OR MISSING
16 fl oz (473 mL)
pai
Pharmaceutical
Associates, Inc.
Greenville, SC 29605

Delivers 5 mL
NDC 0121-1775-05
G UAIFENESINAND C ODEINEP HOSPHATE
O RALS OLUTIONUSP CV
100 mg/10 mg per 5 mL
Expectorant / Cough Suppressant
Alcohol Free / Sugar Free
Package Not Child-Resistant
PHARMACEUTICAL ASSOCIATES, INC.
GREENVILLE, SC 29605
SEE INSERT

Delivers 10 mL
NDC 0121-1550-10
G UAIFENESINAND C ODEINEP HOSPHATE
O RALS OLUTIONUSP CV
200 mg/20 mg per 10 mL
Expectorant / Cough Suppressant
Alcohol Free / Sugar Free
Package Not Child-Resistant
PHARMACEUTICAL ASSOCIATES, INC.
GREENVILLE, SC 29605
SEE INSERT

| Class | Version | Type | Effective |
|---|---|---|---|
| CODEINE ANHYDROUS Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| GUAIFENESIN Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20211129 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-0775-04 | Guaifenesin and Codeine Phosphate | 118 mL in 1 BOTTLE | SOLUTION | 118 | 11 | |
| 0121-0775-08 | Guaifenesin and Codeine Phosphate | 237 mL in 1 BOTTLE | SOLUTION | 237 | 11 | |
| 0121-0775-16 | Guaifenesin and Codeine Phosphate | 473 mL in 1 BOTTLE | SOLUTION | 473 | 11 | |
| 0121-1550-00 | Guaifenesin and Codeine Phosphate | 10 in 1 TRAY | SOLUTION | 10 | 11 | |
| 0121-1550-00 | Guaifenesin and Codeine Phosphate | 10 in 1 CASE | SOLUTION | 10 | 11 | |
| 0121-1550-10 | Guaifenesin and Codeine Phosphate | 10 mL in 1 CUP, UNIT-DOSE | SOLUTION | 10 | 11 | |
| 0121-1550-40 | Guaifenesin and Codeine Phosphate | 10 in 1 TRAY | SOLUTION | 10 | 11 | |
| 0121-1550-40 | Guaifenesin and Codeine Phosphate | 4 in 1 CASE | SOLUTION | 4 | 11 | |
| 0121-1775-00 | Guaifenesin and Codeine Phosphate | 10 in 1 TRAY | SOLUTION | 10 | 11 | |
| 0121-1775-00 | Guaifenesin and Codeine Phosphate | 10 in 1 CASE | SOLUTION | 10 | 11 | |
| 0121-1775-05 | Guaifenesin and Codeine Phosphate | 5 mL in 1 CUP, UNIT-DOSE | SOLUTION | 5 | 11 | |
| 0121-1775-10 | Guaifenesin and Codeine Phosphate | 10 in 1 CASE | SOLUTION | 10 | 11 | |
| 0121-1775-10 | Guaifenesin and Codeine Phosphate | 10 in 1 TRAY | SOLUTION | 10 | 11 | |
| 0121-1775-40 | Guaifenesin and Codeine Phosphate | 4 in 1 CASE | SOLUTION | 4 | 11 | |
| 0121-1775-40 | Guaifenesin and Codeine Phosphate | 10 in 1 TRAY | SOLUTION | 10 | 11 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0121-0775 | GUAIFENESIN AND CODEINE PHOSPHATE SOLUTION [PAI HOLDINGS, LLC] | 11 | Current NDC, Legacy NDC, 3 package rows | 20240907_88d0994c-4270-4408-8837-bd97510b2118.zip |
| 0121-1550 | GUAIFENESIN AND CODEINE PHOSPHATE SOLUTION [PAI HOLDINGS, LLC] | 11 | Current NDC, Legacy NDC, 5 package rows | 20240907_88d0994c-4270-4408-8837-bd97510b2118.zip |
| 0121-1775 | GUAIFENESIN AND CODEINE PHOSPHATE SOLUTION [PAI HOLDINGS, LLC] | 11 | Current NDC, Legacy NDC, 7 package rows | 20240907_88d0994c-4270-4408-8837-bd97510b2118.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0775-04 | ML - Milliliter | 0121-0775 | ac9f8c15-4f02-4667-b975-5c20f7d93dab | 1 | 2012-07-24 |
| 0121-0775-08 | ML - Milliliter | 0121-0775 | ef3933a2-ccb0-4b44-977e-b6b8f9f14e12 | 1 | 2018-02-20 |
| 0121-0775-16 | ML - Milliliter | 0121-0775 | 270b5b4b-ceb0-4155-ad98-6b3454cf2a29 | 1 | 2012-07-24 |
| 0121-1775-00 | ML - Milliliter | 0121-1775 | fdafec21-258c-4805-9ff7-66930e2484d4 | 1 | 2017-08-11 |
| 0121-1775-05 | ML - Milliliter | 0121-1775 | 4eac12b0-97b2-4ef1-bef3-888760717dfa | 1 | 2012-07-24 |
| 0121-1775-10 | ML - Milliliter | 0121-1775 | fe8b87eb-c801-465e-91f8-5a36471e2a43 | 1 | 2012-07-24 |
| 0121-1775-40 | ML - Milliliter | 0121-1775 | 83b2dba4-69f5-4ad4-ad62-88c4211f6184 | 1 | 2024-02-14 |
| 0121-1550-00 | ML - Milliliter | 0121-1550 | b69d5b9d-f7c2-4d33-9f44-67c832179cf2 | 1 | 2017-08-11 |
| 0121-1550-10 | ML - Milliliter | 0121-1550 | dee23321-cef1-46cb-8d6c-347c5e81ccb6 | 1 | 2017-08-11 |
| 0121-1550-40 | ML - Milliliter | 0121-1550 | cdc60019-dabf-48fa-90f2-cd3a54928f5d | 1 | 2024-02-14 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Codeine Phosphate | ACTIVE INGREDIENT | GSL05Y1MN6 | 1 | |
| Guaifenesin | ACTIVE INGREDIENT | 495W7451VQ | 1 | |
| Codeine | ACTIVE MOIETY | Q830PW7520 | 1 | |
| Guaifenesin | ACTIVE MOIETY | 495W7451VQ | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0121-0775 | 0121-0775-04, 0121-0775-08, 0121-0775-16 |
| 0121-1775 | 0121-1775-05, 0121-1775-00, 0121-1775-10, 0121-1775-40 |
| 0121-1550 | 0121-1550-10, 0121-1550-00, 0121-1550-40 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Guaifenesin and Codeine Phosphate | GUAIFENESIN AND CODEINE PHOSPHATE | PAI Holdings, LLC | 88d0994c-4270-4408-8837-bd97510b2118 | 2024-09-06 | Warnings | 0121-1550-40 0121-1775-00 0121-1550-10 0121-0775-16 0121-1550-00 0121-1775-10 0121-0775-04 0121-0775-08 0121-1775-05 0121-1775-40 0121-0775 0121-1550 0121-1775 00121077508 00121177505 00121155040 00121177540 00121177510 00121177500 00121077516 00121155000 00121155010 00121077504 2175415b-f07e-50a6-e063-6394a90acabe 88d0994c-4270-4408-8837-bd97510b2118 |
Adverse event summaries are temporarily unavailable. Other product information remains available.